NorthWest Biotherapeutics Inc (NWBO)

[exwannabe]

Last year (through Nov) the MHRA approved exactly 7 new drugs (not generics) without reliance on another RA.

Those 7 took 480, 420, 410, 400, 400, 330 and 310 days. Not a single one within the 270 days (and I would think at least the CRSPR drug was on the 150 day path).

This year we don't have any new data as the MHRA has decided to stop publishing the data for drugs that are not already approved. So all we have is data on generics (established initials). For those without reliance on other RAs they are averaging about 500 days this year.

With the new IRP in place I wonder if the MHRA will approve more than one or two new drugs a year with more than a rubber stamp.